Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-004619
Filing Date
2025-01-13
Accepted
2025-01-13 09:24:53
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A revb_form_defa14a_2025-0.htm DEFA14A 38202
2 GRAPHIC img157140444_0.jpg GRAPHIC 18521
  Complete submission text file 0000950170-25-004619.txt   64236
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

EIN.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39603 | Film No.: 25525100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)